Purpose-built cohorts of standard-of-care patients to support phase II-to-phase III oncology drug development decisions by providing comparator groups with data mirroring targeted trials.

A research-ready network that accelerates oncology clinical trials by engaging diverse and underrepresented patient populations in community oncology settings.